Bbs7tm1b(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Bbs7tm1b(EUCOMM)Wtsi |
Name: |
Bardet-Biedl syndrome 7; targeted mutation 1b, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:5554939 |
Gene: |
Bbs7 Location: Chr3:36627291-36667626 bp, - strand Genetic Position: Chr3, 17.72 cM, cytoband B
|
Alliance: |
Bbs7tm1b(EUCOMM)Wtsi page
|
IMPC: |
Bbs7 gene page |
|
Mutant Cell Line: |
EPD0776_3_C08 |
Germline Transmission: |
Earliest citation of germline transmission:
J:188991
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 36661411 of Chromosome 3 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site was followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted downstream of the targeted exon(s) at position 36662296. The critical exon(s) were thus flanked by loxP sites, and subsequent Cre-mediated excision deleted the critical sequence and the neomycin selection cassette yielding a knockout reporter allele. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:155845, J:173534, J:188991)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:188991 The Jackson Laboratory, Alleles produced for the KOMP project by The Jackson Laboratory. MGI Direct Data Submission. 2012; |
All: |
8 reference(s) |
|